Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
Open-market buys, last 90 days
$29,501
in 3 filings
Open-market sales, last 90 days
$27,505
in 1 filing, $28K under 10b5-1 plans

Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-01-29 JANTZ DEREK Chief Scientific Officer Sale −6,444 $12.25 $79K 3,907,345
2021-01-29 JANTZ DEREK Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) −21,515 258,168
2021-01-28 JANTZ DEREK Chief Scientific Officer Exercise or conversion +21,514 $0.04 $861 3,898,718
2021-01-28 JANTZ DEREK Chief Scientific Officer Sale −6,444 $11.97 $77K 3,892,274
2021-01-28 JANTZ DEREK Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) −21,514 279,683
2021-01-27 JANTZ DEREK Chief Scientific Officer Exercise or conversion +21,514 $0.04 $861 3,884,252
2021-01-27 JANTZ DEREK Chief Scientific Officer Sale −7,048 $11.68 $82K 3,877,204
2021-01-27 JANTZ DEREK Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) −21,514 301,197
2021-01-26 KANE MATTHEW R. President and CEO Exercise or conversion +21,515 $0.04 $861 1,863,708
2021-01-26 KANE MATTHEW R. President and CEO Sale −9,697 $13.37 $130K 1,854,011
2021-01-26 KANE MATTHEW R. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −21,515 258,168
2021-01-25 KANE MATTHEW R. President and CEO Exercise or conversion +21,514 $0.04 $861 1,851,888
2021-01-25 KANE MATTHEW R. President and CEO Sale −9,695 $13.74 $133K 1,842,193
2021-01-25 KANE MATTHEW R. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −21,514 279,683
2021-01-22 KANE MATTHEW R. President and CEO Exercise or conversion +21,514 $0.04 $861 1,840,592
2021-01-22 KANE MATTHEW R. President and CEO Sale −10,218 $13.53 $138K 1,830,374
2021-01-22 KANE MATTHEW R. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −21,514 301,197
2021-01-21 THOMSON DAVID S. Chief Operating Officer Sale −10,000 $16.49 $165K 109,243
2020-08-31 Scimeca Dario General Counsel and Secretary Grant or award +3,156 $4.79 $15K 5,228
2020-08-21 KANE MATTHEW R. President and CEO Grant or award · Employee Stock Option (Right to Buy) +1,743 1,743

Page 24 of 28 · 549 trades